CD4 and pneumocystosis: Although most of the patients had an available CD4 count tested within a 6-month period (26; 63.4%), many of them did not receive co-trimoxazole prophylactic treatment (10) against opportunistic infections, such as Pneumocystis jirovecii pneumonia.